-
New review points to faster, safer vaccine development
Viral mimic systems and other tech platforms could enable local testing of vaccine candidates and antiviral therapies. This is important... Read more -
Ostarine: The performance-enhancing drug giving anti-doping agencies a headache
A drug designed to help cancer patients rebuild wasting muscles has become one of the most contentious substances in elite... Read more -
The outrage over the Enhanced Games ignores the risks many already accept in sport
The Enhanced Games, slated to commence in May 2026, has sparked outrage across the sporting world. This new competition is... Read more -
Weight-loss wonder pills prompt scrutiny of their key ingredient
Blockbuster weight-loss drugs are transforming the way we treat obesity. But while costly injectable versions remain out of reach for... Read more -
Predicting and preventing the risk of hip fracture related to osteoporosis
Researchers at Pompeu Fabra University (UPF) have made a great leap toward predicting the risk of hip fracture among people... Read more -
HIV entry blocker pairs CD4 mimic and antibody, showing sevenfold higher efficacy
Drug conjugates (ADCs) developed at Institute of Science Tokyo combine a CD4 mimic with neutralizing antibodies for enhanced suppression of... Read more -
Key brain DMT theory takes a hit: Rat study finds no detectable DMT in serotonin neurons
For decades, the idea that the human brain might naturally produce the psychedelic compound DMT has attracted considerable attention. It... Read more -
Taking the next shot: GLP-1 research and the new era of weight loss
Soaring in popularity, GLP-1 medications—from weekly injections to newly available pills—are rapidly reshaping how Americans think about weight loss. In... Read more -
Single dose of a psychedelic drug can rapidly reduce depressive symptoms, clinical trial suggests
A single dose of the psychedelic drug dimethyltryptamine (DMT), given with psychological support, rapidly reduced depressive symptoms in 34 adults... Read more -
Younger men experience more harms using steroids than older men, study finds
Younger men who use anabolic-androgenic steroids (AAS) experience a greater overall burden and complexity of harms than older men, new... Read more -
Ketamine's 'mystical' effects fail to explain alcohol abstinence gains, study suggests
The psychedelic effects recreational users often seek from taking ketamine do not predict the therapeutic benefits for people being treated... Read more -
Alzheimer's gene boosts seizures, but pathway can be targeted, study finds
The gene most strongly correlated with Alzheimer's disease also boosts seizure activity by decreasing levels of ion pumps and energy-producing... Read more -
Helping mothers with epilepsy take life-saving medication without fear of birth defects
Scientists are moving toward a genetic test that could help thousands of mothers with epilepsy safely take life-saving medication without... Read more -
Research: FDA drug labels not proof of patent violation
Federal law requires every prescription drug to include a document describing dosing guidelines, contraindications, results from clinical trials and safety... Read more -
Will Ozempic-style patches help you lose weight? Two experts explain
Could a simple patch, inspired by the weight-loss drug Ozempic, really help you shed excess kilos without the pain and... Read more
